The Patent Finder

Repros Therapeutics Inc.

Also on record
Records under this name other than patents Repros Therapeutics Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Repros Therapeutics Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,519,004Dosing regimes for trans-clomiphene
Formerly held
Lapsed on the fee record
Ended Aug 27, 2025 · USPTO record
Lapsed on the fee recordEnded Aug 27, 2025USPTO record
US 9,687,458Trans-clomiphene for use in cancer therapy
Lapsed on the fee record
Ended Jun 27, 2025 · USPTO record
Lapsed on the fee recordEnded Jun 27, 2025USPTO record
US 8,426,394Progesterone antagonists such as CDB-4124 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer, etc
Formerly held
Lapsed on the fee record
Ended Apr 23, 2025 · USPTO record
Lapsed on the fee recordEnded Apr 23, 2025USPTO record
US 9,616,034Trans-clomiphene and its analogues as agents that increase bone mineral density
Lapsed on the fee record
Ended Apr 11, 2025 · USPTO record
Lapsed on the fee recordEnded Apr 11, 2025USPTO record
US 9,616,074Compositions and methods for suppressing endometrial proliferation
Formerly held
Lapsed on the fee record
Ended Apr 11, 2025 · USPTO record
Lapsed on the fee recordEnded Apr 11, 2025USPTO record
US 8,377,991Trans-clomiphene for metabolic syndrome
Lapsed on the fee record
Ended Feb 19, 2025 · USPTO record
Lapsed on the fee recordEnded Feb 19, 2025USPTO record
US 8,372,887Trans-clomiphene for metabolic syndrome
Lapsed on the fee record
Ended Feb 12, 2025 · USPTO record
Lapsed on the fee recordEnded Feb 12, 2025USPTO record
US 9,545,411Methods and compositions for treating progesterone-dependent conditions
Formerly held
Lapsed on the fee record
Ended Jan 17, 2025 · USPTO record
Lapsed on the fee recordEnded Jan 17, 2025USPTO record
US 8,247,456Dosing regimes for trans-clomiphene
Formerly held
Lapsed on the fee record
Ended Aug 21, 2024 · USPTO record
Lapsed on the fee recordEnded Aug 21, 2024USPTO record
US 9,283,234Compositions and methods for suppressing endometrial proliferation
Formerly held
Lapsed on the fee record
Ended Mar 15, 2024 · USPTO record
Lapsed on the fee recordEnded Mar 15, 2024USPTO record
10 of 45 patents shown.
Pro members see all 45.
Pro members: see all 45 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited